“Lebrikizumab Improves Atopic Dermatitis in Adult and Adolescent Patients With Skin of Color: 16-Week Results From the ADmirable Study”, J of Skin, vol. 9, no. 1, p. s515, Jan. 2025, doi: 10.25251/skin.9.supp.515.